44.42
price down icon2.35%   -1.07
after-market Dopo l'orario di chiusura: 44.52 0.10 +0.23%
loading
Precedente Chiudi:
$45.49
Aprire:
$45.56
Volume 24 ore:
1.44M
Relative Volume:
0.67
Capitalizzazione di mercato:
$5.50B
Reddito:
$692.26M
Utile/perdita netta:
$-512.41M
Rapporto P/E:
-10.48
EPS:
-4.24
Flusso di cassa netto:
$-274.36M
1 W Prestazione:
-4.39%
1M Prestazione:
-10.98%
6M Prestazione:
-5.91%
1 anno Prestazione:
+39.12%
Intervallo 1D:
Value
$44.30
$45.56
Intervallo di 1 settimana:
Value
$44.30
$47.00
Portata 52W:
Value
$20.14
$53.42

Guardant Health Inc Stock (GH) Company Profile

Name
Nome
Guardant Health Inc
Name
Telefono
855-698-8887
Name
Indirizzo
3100 HANOVER STREET, PALO ALTO
Name
Dipendente
2,021
Name
Cinguettio
@guardanthealth
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
GH's Discussions on Twitter

Confronta GH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
GH
Guardant Health Inc
44.42 5.64B 692.26M -512.41M -274.36M -4.24
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
478.32 179.32B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
205.48 145.22B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
565.19 44.23B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
199.17 34.14B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.18 34.19B 6.63B 1.17B 1.19B 4.05

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Iniziato Mizuho Outperform
2025-01-23 Iniziato Barclays Overweight
2024-06-28 Aggiornamento Guggenheim Neutral → Buy
2024-06-03 Ripresa Jefferies Buy
2024-04-24 Ripresa Craig Hallum Buy
2023-12-14 Iniziato Guggenheim Neutral
2023-12-13 Iniziato Wolfe Research Peer Perform
2023-11-13 Aggiornamento Raymond James Mkt Perform → Outperform
2023-09-28 Iniziato Bernstein Outperform
2023-09-27 Aggiornamento Piper Sandler Neutral → Overweight
2023-07-05 Ripresa JP Morgan Overweight
2023-05-26 Aggiornamento Citigroup Neutral → Buy
2023-05-05 Iniziato UBS Buy
2023-03-09 Downgrade Citigroup Buy → Neutral
2023-01-05 Iniziato Scotiabank Sector Outperform
2022-11-01 Downgrade Piper Sandler Overweight → Neutral
2022-10-19 Iniziato Craig Hallum Buy
2022-10-06 Iniziato Stephens Overweight
2022-08-25 Iniziato Credit Suisse Outperform
2022-06-03 Iniziato Piper Sandler Overweight
2022-04-28 Ripresa BTIG Research Buy
2022-02-24 Reiterato Canaccord Genuity Buy
2022-02-24 Reiterato Citigroup Buy
2022-02-24 Reiterato Cowen Outperform
2022-02-24 Reiterato Morgan Stanley Overweight
2022-02-24 Reiterato SVB Leerink Outperform
2022-02-24 Reiterato Stifel Buy
2022-02-24 Reiterato Wells Fargo Overweight
2021-10-15 Ripresa Cowen Outperform
2021-06-15 Iniziato Raymond James Mkt Perform
2021-06-03 Iniziato Goldman Buy
2021-05-25 Iniziato Wells Fargo Overweight
2021-01-11 Iniziato Stifel Buy
2020-09-09 Iniziato Morgan Stanley Overweight
2020-06-12 Iniziato BTIG Research Buy
2020-02-21 Iniziato Guggenheim Buy
2020-01-07 Iniziato Citigroup Buy
2019-08-07 Reiterato Canaccord Genuity Buy
2019-04-16 Iniziato Canaccord Genuity Buy
2019-04-10 Aggiornamento BofA/Merrill Neutral → Buy
2019-02-28 Reiterato BofA/Merrill Neutral
2018-10-29 Iniziato BofA/Merrill Neutral
2018-10-29 Iniziato JP Morgan Overweight
2018-10-29 Iniziato William Blair Outperform
Mostra tutto

Guardant Health Inc Borsa (GH) Ultime notizie

pulisher
12:55 PM

What institutional investors are buying Guardant Health Inc. stockUnprecedented market success - jammulinksnews.com

12:55 PM
pulisher
11:25 AM

What catalysts could drive Guardant Health Inc. stock higher in 2025Lightning-fast growth - jammulinksnews.com

11:25 AM
pulisher
10:38 AM

What are Guardant Health Inc. company’s key revenue driversCapitalize on emerging market sectors - jammulinksnews.com

10:38 AM
pulisher
05:28 AM

What are the latest earnings results for Guardant Health Inc.Maximize returns with timely market signals - jammulinksnews.com

05:28 AM
pulisher
Jul 26, 2025

What makes Guardant Health Inc. stock price move sharplyCapital Safe Stock Watchlist - Metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga

Jul 26, 2025
pulisher
Jul 25, 2025

Guardant Health Enrolls First Patient in NCI Vanguard Study for Multi-Cancer Detection Test - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Guardant Health Inc. stock priceConsistent wealth multiplication - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem - GlobeNewswire Inc.

Jul 25, 2025
pulisher
Jul 25, 2025

Is Guardant Health Inc. a good long term investmentDynamic growth stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

1 Healthcare Stock with Solid Fundamentals and 2 We Avoid - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Guardant Health Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

10 Best Mid Cap Pharma Stocks to Buy - Insider Monkey

Jul 23, 2025
pulisher
Jul 23, 2025

Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut. - Business Insider

Jul 23, 2025
pulisher
Jul 23, 2025

Guardant Health (NASDAQ:GH investor five-year losses grow to 44% as the stock sheds US$228m this past week - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Guardant Health Inc. Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

Cathie Wood’s ARK ETFs shift focus, buying NVIDIA and selling GUARDANT - Investing.com

Jul 22, 2025
pulisher
Jul 21, 2025

Freenome's new CEO is ready to compete in race for tests that can detect cancer early - The Business Journals

Jul 21, 2025
pulisher
Jul 19, 2025

Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - Benzinga

Jul 19, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health Director Sells 142 Shares at $48.2 Per Share on 2025-07-17. - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Lung Cancer Diagnostics Market Expansion Driven by Liquid - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

(GH) Technical Data - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 15, 2025

User - FinancialContent

Jul 15, 2025
pulisher
Jul 15, 2025

Evercore ISI Keeps Their Buy Rating on Guardant Health (GH) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - BioSpace

Jul 15, 2025
pulisher
Jul 14, 2025

Guardant Health stock price target maintained at $60 by Evercore ISI - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Press Release: Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - 富途牛牛

Jul 14, 2025

Guardant Health Inc Azioni (GH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Guardant Health Inc Azioni (GH) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
POTTER MYRTLE S
Director
Jul 17 '25
Sale
48.20
26
1,253
18,196
Hidalgo Medina Manuel
Director
Jul 17 '25
Option Exercise
0.00
2,784
0
2,784
diagnostics_research WAT
$302.95
price up icon 1.50%
diagnostics_research DGX
$168.55
price down icon 1.95%
$138.90
price down icon 1.53%
diagnostics_research LH
$264.96
price down icon 1.02%
diagnostics_research MTD
$1,263.99
price up icon 0.26%
diagnostics_research A
$120.18
price down icon 0.14%
Capitalizzazione:     |  Volume (24 ore):